Small scale production meets upscale performance
It’s finally arrived: the market’s first premium separator for single-use biopharmaceutical processing. Alfa Laval centrifuges have long set the industry standard for top-quality cell culture separation. With the new Alfa Laval CultureOne, all of our unique innovations for gentle treatment and increased yield are now available in a solution for single-use biopharma processing. CultureOne brings maximum separation efficiency while creating new possibilities for processing cell-culture-based fermentations.
Premium, proven performance. Learn more in our white paper.
CultureOne is a premium and scalable centrifugal separation system with single-use components. Thanks to our well-proven design features, it enables efficient separation with minimal lyses for new benefits in single-use processing environments. One recent study, for example, has shown that CultureOne can deliver yields of up to 98%. Read more about this in our new white paper.
Superior processing with predictable and scalable performance
Alfa Laval CultureOne is a scalable platform, based on Alfa Laval’s well proven disc-stack technology to support the industry’s need for improved productivity.
True hermetic design: the best quality and safety guarantee
The secret behind CultureOne’s performance is the new Alfa Laval Spinsert™. This patented, replaceable and recyclable insert comes with all of our unique features, including Alfa Laval’s fully Hermetic Design, as well as the TopStream™ and UniDisc™ technologies.
Developed with the industry to meet today’s demands
Alfa Laval has partnered with leading biopharmaceutical producers to verify process performance under a wide variety of process conditions, ensuring CultureOne is a flexible solution to meet ever-changing process demands.
“In these extraordinary times when ‘health and safety’ is on top of everyone’s agenda, I am pleased to announce the launch of our unique system that facilitates and secure safe and efficient biopharmaceutical processing. Now we can offer a premium separation technology for more effective production of smaller batches of targeted treatments. It is beneficial for both our customers and the society.”
Nish Patel, President of the Food & Water Division
Ready for production – today
If you are looking to improve productivity in your single-use biopharma operation, there’s no reason to wait. CultureOne Primo is ready for production with all the documentation needed for validation in your GMP environment. Get in touch to find out more.
Why switch to single-use processing?
There are many reasons why more biopharma manufacturers are getting rid of sterilization equipment in favour of single-use processing solutions. Greater assurance of patient safety is key: just like single-use syringes in doctor’s offices, single-use technologies offer the best prevention of cross-contamination between batches. And single-use processing also means a reduced footprint and increased flexibility, making it possible to bring important new treatments to market faster than ever before.
Don’t miss our upcoming webinars
Want to learn more about the advantages of single-use processing and how CultureOne can benefit you? Register to meet Alfa Laval separation experts at our upcoming webinars to find out everything you need to know.
Do you want to know more?
Get in touch with an expert or register for an upcoming webinar.
For more information about the product contact
Market Area Manager
Food & Water Division, Separation & Systems
Alfa Laval Nordic A/S
Mobile: +45 27 77 86 55
Alfa Laval is launching the first premium separator system for single-use biopharmaceutical processing
The biopharmaceutical industry has seen a major shift toward more flexible cell culture production systems that rely on smaller facilities with single-use processing equipment.
The Separator Innovator
Want to know more about the unique innovations in Alfa Laval’s separation technology? We have been reinventing centrifuge technology for over 130 years. On our Separator Innovator hub, we share much of the knowledge we have learned along the way.